Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine

PHASE4CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

May 21, 2020

Study Completion Date

May 21, 2020

Conditions
Neuromuscular Blockade Reversal AgentSugammadexNeostigmineQuality of RecoveryLaparoscopic Cholecystectomy
Interventions
DRUG

Sugammadex

sugammadex 2mg/kg or 4mg/kg according to Train-of-four count (TOF 0 : 4mg/kg, TOF 1-4 : 2mg/kg)

DRUG

Neostigmine

with glycopyrrolate 0.4mg, neostigmine 0.02mg/kg or 0.04mg/kg or 0.05mg/kg according to Train-of-four count (TOF 0 : wait until TOF 2, TOF2-3: 0.05mg/kg, TOF4: 0.04mg/kg)

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT04332627 - Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine | Biotech Hunter | Biotech Hunter